New drug combo aims to cut heart attack risk after hip fracture
NCT ID NCT07228663
First seen Nov 14, 2025 · Last updated May 02, 2026 · Updated 20 times
Summary
This study tests whether a combination of two blood thinners (rivaroxaban and aspirin) can prevent heart attacks, strokes, and blood clots after hip fracture surgery in patients who had a heart injury. About 100 adults aged 45 and older will take either the combo for 90 days or standard clot prevention for 30 days. The goal is to see if a larger trial is possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM (VTE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Humanitas Research Hospital
Milan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Juravinski Hospital
Hamilton, Ontario, L8V 1C3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St.Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.